Walden Group Healthcare M&A Blog

GTCR-Backed Corza Medical Purchases Ophthalmic Instrument maker Katena Products Inc. from Audax Management

12/6/2021
Katena adds ophthalmic products used across cataract, glaucoma and corneal surgeries, including surgical instruments, single-use devices and specialty biologics that have been sold in more than 110 countries to more than 5,000 customers, including hospitals, ambulatory surgery centers and distributors. Katena has more than 200 employees across...
Read More
Resonetics to Acquire Hudson Medical Innovations

11/16/2021
Device contract micro manufacturer Resonetics, LLC focused on product development, including laser processing, tubing, metal fabrication and other manufacturing services and subsidiary of GTCR-backed Regatta Medical has purchased Hudson Medical Innovations, a producer of microfluidics, point-of-care diagnostics reagents, biosensors, and advanced...
Read More
The Walden Group Releases Q3 2021 Strategic Healthcare M&A Report

11/1/2021
The Walden Group is pleased to provide access to its Q3 2021 Strategic Healthcare M&A Report, which includes: Market Overview Major M&A Deals by Sector What the CEOs are Saying Selected Recent Healthcare IPOs Key Stats on Top M&A Deals in 2021 Performance of Leading Healthcare Companies ...
Read More
Hologic to Acquire Bolder Surgical for $160m

10/18/2021
Hologic, Inc., a $3.8b producer of diagnostics, imaging systems and surgical products for women's health, has acquired Bolder Surgical, LLC, a developer of advanced energy vessel sealing surgical devices. The deal adds a differentiated portfolio of advanced vessel sealing and dissection tools used in laparoscopic procedures. To date, Bolder has...
Read More
Boston Scientific to Acquire Devoro Medical, Inc. for $320m

10/4/2021
Boston Scientific Corporation (NYSE: BSX; “BSX“), a $10b producer of interventional technologies for general surgery, neurosurgery, and cardiovascular health has announced the acquisition of Devoro Medical, a developer of a blood clot retrieval and removal system for arterial and venous systems. BSX has been a minority investor in Devoro...
Read More